Rafferty Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Rafferty Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-39,187	Closed	-$7.2M	–	1332
2021 Q2	$7.2M	Sell	39,187 -10,729	-21%	-$1.97M	0.05%	233
2021 Q1	$7.63M	Buy	49,916 +14,615	+41%	+$2.23M	0.05%	206
2020 Q4	$5.52M	Sell	35,301 -12,299	-26%	-$1.92M	0.05%	199
2020 Q3	$5.45M	Buy	47,600 +9,878	+26%	+$1.13M	0.07%	168
2020 Q2	$4.23M	Buy	37,722 +9,381	+33%	+$1.05M	0.06%	197
2020 Q1	$2.55M	Sell	28,341 -35,197	-55%	-$3.16M	0.11%	112
2019 Q4	$6.87M	Sell	63,538 -17,212	-21%	-$1.86M	0.11%	106
2019 Q3	$7.91M	Buy	80,750 +19,309	+31%	+$1.89M	0.12%	91
2019 Q2	$8.05M	Buy	61,441 +7,144	+13%	+$936K	0.14%	87
2019 Q1	$7.34M	Buy	54,297 +37,827	+230%	+$5.11M	0.12%	90
2018 Q4	$1.6M	Buy	16,470 +173	+1%	+$16.8K	0.04%	275
2018 Q3	$2.27M	Sell	16,297 -5,138	-24%	-$714K	0.04%	248
2018 Q2	$2.66M	Buy	21,435 +7,952	+59%	+$987K	0.04%	218
2018 Q1	$1.5M	Buy	13,483 +642	+5%	+$71.6K	0.02%	393
2017 Q4	$1.54M	Buy	12,841 +2,181	+20%	+$261K	0.03%	311
2017 Q3	$1.5M	Sell	10,660 -1,884	-15%	-$264K	0.03%	326
2017 Q2	$1.53M	Buy	12,544 +3,126	+33%	+$380K	0.04%	251
2017 Q1	$1.14M	Buy	9,418 +1,030	+12%	+$125K	0.03%	319
2016 Q4	$1.03M	Buy	8,388 +2,804	+50%	+$343K	0.05%	174
2016 Q3	$684K	Buy	5,584 +889	+19%	+$109K	0.03%	281
2016 Q2	$548K	Sell	4,695 -1,368	-23%	-$160K	0.04%	379
2016 Q1	$844K	Buy	6,063 +1,378	+29%	+$192K	0.05%	266
2015 Q4	$896K	Sell	4,685 -459	-9%	-$87.8K	0.11%	225
2015 Q3	$804K	Buy	5,144 +42	+0.8%	+$6.57K	0.06%	276
2015 Q2	$922K	Buy	5,102 +326	+7%	+$58.9K	0.06%	237
2015 Q1	$828K	Buy	4,776 +2,009	+73%	+$348K	0.06%	267
2014 Q4	$512K	Buy	2,767 +701	+34%	+$130K	0.12%	193
2014 Q3	$343K	Buy	+2,066	New	+$343K	0.04%	230
2014 Q2	–	Sell	-2,687	Closed	-$409K	–	410
2014 Q1	$409K	Buy	2,687 +596	+29%	+$90.7K	0.08%	108
2013 Q4	$278K	Buy	+2,091	New	+$278K	0.07%	193